Little is known about the current clinical profile and outcomes of patients with infective endocarditis (IE) in South Africa (SA). Objectives. To provide a contemporary and descriptive overview of IE in a representative SA tertiary centre. Methods. We conducted a retrospective review of the records of patients admitted to Groote Schuur Hospital, Cape Town, between 2009 and 2016 fulfilling universal criteria for definite or possible IE, in search of demographic, clinical, microbiological, echocardiographic, treatment and outcome information. Results. A total of 105 patients fulfilled the modified Duke criteria for IE. The median age of the cohort was 39 years (interquartile range (IQR) 29 -51), with a male preponderance (61.9%). The majority of the patients (72.4%) had left-sided native valve endocarditis, 14.3% had right-sided disease, and 13.3% had prosthetic valve endocarditis. A third of the cohort had rheumatic heart disease. Although 41.1% of patients with left-sided disease had negative blood cultures, the three most common organisms cultured in this subgroup were Staphylococcus aureus (18.9%), Streptococcus spp. (16.7%) and Enterococcus spp. (6.7%). Participants with right-sided endocarditis were younger (29 years, IQR 27 -37) and were mainly intravenous drug users (73.3%), and the majority cultured positive for S. aureus (73.3%) with frequent septic pulmonary complications (40.0%). The overall in-hospital mortality was 16.2%, with no deaths in the group with rightsided endocarditis. Predictors of death in our patients were heart failure (odds ratio (OR) 8.16, 95% confidence interval (CI) 1.77 -37.70; p=0.007) and age >45 years (OR 4.73, 95% CI 1.11 -20.14; p=0.036). Valve surgery was associated with a reduction in mortality (OR 0.09, 95% CI 0.02 -0.43; p=0.001). Conclusions. IE remains an important clinical problem in a typical teaching tertiary care centre in SA. In this setting, it continues to affect mainly young people with post-inflammatory valve disease and congenital heart disease. The in-hospital mortality associated with IE remains high. Intravenous drug-associated endocarditis caused by S. aureus is an important IE subset, comprising ~10% of all cases, which was not reported 15 years ago, and culture-negative endocarditis remains highly prevalent. Heart failure in IE carries a significant risk of death and needs a more intensive level of care in hospital. Finally, cardiac surgery was associated with reduced mortality, with the largest impact in patients with heart failure.
RESEARCH
Despite advances in diagnostic imaging, antimicrobial treatment and cardiac surgery, infective endocarditis (IE), as defined by the modified Duke criteria, [1] remains a potentially fatal condition with an annual in-hospital mortality rate of ~20%. [2, 3] Observational data from the developed world indicate that the profile of IE has changed significantly over the past four decades. IE has become a disease that predominantly affects older and/or diabetic patients with infections on degenerative native valves or prosthetic valves. Rheumatic heart disease (RHD) has all but disappeared as a predisposing risk factor. [4] [5] [6] The classic clinical signs of IE are now infrequent, patients often presenting with only fever and/ or a heart murmur. [4] Furthermore, endocarditis caused by oral organisms (such as Streptococcus viridans) and culture-negative endocarditis have both declined significantly as a proportion of IE in the developed world. [4] Nosocomial infections from longterm indwelling catheters and intravenous lines are increasing in incidence, and Staphylococcus aureus, coagulase-negative S. aureus and Enterococcus spp. are the dominant organisms. [7] In spite of this evolution in the patient and clinical profile of IE, in-hospital mortality, morbidity and complication rates remain high. Specifically, congestive cardiac failure, stroke and intracardiac abscesses with conduction abnormalities are reported at frequencies of ~60%, 30% and 1 -15%, respectively. [8] [9] [10] [11] Apart from a recent focus on intravenous (IV) drug use (IVDU)-related IE, [12] there are few contemporary data on IE from South Africa (SA) or sub-Saharan Africa (SSA), with the most recent information on the subject published in 2003. [13] Specifically, there is a dearth of information on patient profiles, risk factors, predisposing cardiac conditions, and the spectrum of causative microbiological organisms. Furthermore, little is known about the prevalence and predictors of complications, the proportion of patients with IE who undergo surgery, and in-hospital mortality rates in SSA. This knowledge is vital for increasing the survival of IE patients as well as improving their overall care by optimising local clinical practice.

Methods
This was a retrospective review of patient records. Patients aged >17 years with complete data who fulfilled the modified Duke criteria for IE [14] [15, 16] Unadjusted and adjusted odds ratios (ORs) were presented with 95% confidence intervals (CIs).
Results
One hundred and five cases were included in the study (Fig. 1) , with 64.8% (n=68) and 35.8% (n=37) of patients fulfilling the modified Duke criteria for definite and possible IE, respectively. In all cases, the responsible clinicians felt it appropriate to commence treatment for endocarditis. There was a steady increase in the number of cases seen over the period from 2009 to 2016, with a peak in 2014 (Supplementary File 1, available at http://www.samj.org.za/public/ sup/Supplementary.pdf).
The median age of the cohort was 39 years (interquartile range (IQR) 29 -51), with a slight male preponderance (61.9%). The majority of the patients had left-sided native valve endocarditis (72.4%), while the remainder were evenly split between prosthetic valve endocarditis (13.3%) and right-sided endocarditis (14.3%).
The most common underlying cardiac conditions were RHD (34.3%), mechanical or tissue prosthetic valves (13.3%; most of these patients had had valve surgery for RHD), and congenital heart disease (10.5%). Five patients (4.8%) had a prior history of IE and 1 patient had device-associated endocarditis (permanent pacemaker). Among those who were tested for HIV (87/105 patients), 23.0% were seropositive. Ten patients (9.5%) had diabetes mellitus, while other comorbidities such as chronic kidney disease, chronic liver disease and cancer were uncommon (3 patients each). One patient had a permanent IV port. Table 1 gives a detailed description of the clinical characteristics, special investigations and laboratory results. The most frequent presenting signs and symptoms were fever (63.8%), dyspnoea (61.0%), a temperature >38.5°C (58.1%) and weight loss (24.8%). Most patients (85.7%) had a new or changed murmur on clinical examination. More than a quarter (27.6%) had an acute neurological deficit, and 18.1% were noted to have splinter haemorrhages (Table 2 ).
All patients had a transthoracic echocardiogram. Where vegetations were detected, the mitral valve (52.9%) and aortic valve (37.6%) were most frequently affected. Two-thirds (68.4%) of the patients with aortic valve involvement had severe aortic regurgitation, whereas 54.1% of those with mitral involvement and 36.4% of those with tricuspid involvement had severe regurgitation.
The median number of blood cultures done per patient was 3 (IQR 2.5 -4.5). Blood cultures were persistently positive after 48 hours in 21.0% of patients in this study (13.2% of left-sided native endocarditis, 42.9% of prosthetic valve endocarditis and 40.0% of right-sided endocarditis; p=0.006). Based on the attending clinician's evalua tion, the most frequent sources of infection were thought to be the skin (66.7%), oral cavity (25.9%) and gastrointestinal tract (7.9%). Of patients with left-sided disease, 40.7% had negative blood cultures (Fig. 2, A) , and the three most common organisms cultured in this subgroup were S. aureus (18.7%), Streptococcus spp. (16.5% (S. viridans 9.9%, other 6.6%)) and Enterococcus spp. (6.6%).
Right-sided disease differed from leftsided disease. Patients with tricuspid and pulmonary valve endocarditis were younger than those with left-sided disease (median age 29.1 years, IQR 27 -37) and had a greater male predominance (73.3%), IVDU was a common risk behaviour (73.3%) and
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Fig. 1. Patients included in the study. (IE = infective endocarditis.)
RESEARCH S. aureus was the most common organism cultured (73.3%), while 13.3% of patients were culture-negative (Fig. 2, B) .
In-hospital course and outcome
Heart failure was the most common in-hospital complication (42.9%) ( (Table 4) ; however, data sparsity reduced the precision of these estimates. HIV, diabetes and infection with S. aureus did not appear to influence mortality. The most common complications for right-sided disease were septic pulmonary emboli (40.0%) and acute kidney injury (40.0%). All patients were treated with antibiotics, and 44 (42.3%) underwent valve surgery. Heart failure was the most common indication for surgery (66.7%; p=0.001). Surgery was associated with a reduced risk 
Discussion
We have presented a retrospective review of the hospital records of patients admitted to an SA urban tertiary referral centre with a diagnosis of IE. The study, which covered the period between 2009 and 2016, is the first of its kind since the early 2000s and describes the demographic, clinical and microbiological profile of patients with the disease, discusses treatment strategies, and provides information about in-hospital outcomes and their predictors.
The main findings of this study demonstrate that IE in urban SA remains a disease of relatively young people (median age 39 years) with rheumatic or congenital heart disease (44.8%); culture-negative endocarditis remains a prevalent problem; the proportion of IE caused by community-acquired S. aureus appears to be growing; and there is evidence that IVDU-associated rightsided endocarditis is now an important problem. Furthermore, we found that heart failure was the most common complication of IE, was the most important predictor of death and was the main reason patients were referred for cardiac surgery, an intervention that was associated with reduced mortality rates. Finally, HIV, diabetes, alcohol use and chronic kidney disease were not important predictors of a poor outcome.
Although no major conclusions can be made from a retrospective review, or from comparisons with other studies, it is interesting to compare our findings with data from recent international registries [4, [17] [18] [19] [20] and a similar but older SA study. [13] When compared with our findings, these registries suggest that there are major differences in the age profile (>70 years v. <40 years), clinical profile (degenerative valve disease v. RHD) and microbiological profile of the studied IE patients, with apparently fewer cases of culturenegative and oral organism-related IE seen in the developed world.
Additionally, in comparison with findings from the earlier SA study, [13] the main observed differences revolved around the microbiological profile, proportion of IVDU-associated right-sided disease, and prevalence of underlying congenital heart disease.
Whereas community-associated S. aureus was noted infrequently in 2003, it was found in 26% of our overall cohort and was the dominant cause of infection in patients with IVDU-associated IE. This is in line with a recently published study from Johannesburg, which found S. aureus to be present in 61% of recreational drug users who developed IE. [12] The same study reported a higher burden of right-sided endocarditis at their centre compared with our findings. This finding could possibly be explained by recent data on drug abuse in SA that showed higher rates of IVDU in Gauteng Province than in the Western Cape. [21] On the other hand, viridans group streptococci, which were previously dominant, may be diminishing in frequency. The high rate of culture-negative IE in our cohort was in line with the previous study and other low-and middle-income country (LMIC) data, as demonstrated in a systematic review by Njuguna et al. [22] High rates of empirical administration of antibiotics prior to blood culture collection are often cited as the main reason for high culture-negative IE rates. Of patients with culture-negative IE in our study, 24.8% had received antibiotics prior to blood culture collection. Culture- RESEARCH negative rates are significantly lower in higher-income countries (10%). [4] Mortality in our cohort (16.2%) was lower than figures previously reported in other LMICs (19 -46%). [22] A possible explanation for this relatively lower than expected mortality was the liberal use of cardiac surgery for patients with international guideline-based recommendations such as heart failure. [23] Approximately 48% of patients with left-sided IE underwent surgery, a much higher figure than those reported in other LMIC registries, where ~15% receive valve replacement for the same indication. [22, 24] 
Study strengths and limitations
To the best of our knowledge, this is the largest cohort of IE patients in SSA to date and provides important information and insight into the disease in an SA context. There are a number of important limitations of this study, including that it was a single-centre, retrospective study; that the number of participants was relatively small; that the subgroup sizes were relatively small and unequal; that it is likely that not all patients with IE over the given period of interest were captured; and that some patient records may have been incomplete and their International Statistical Classification of Diseases and Related Health Problems, 9th revision (ICD-9) and ICD-10 information may not always have been accurate. As a result of these and other limitations inherent in the design and conduct of such a study, caution needs to be exercised with regard to the conclusions drawn as well as the generalisability of the findings.
Conclusions
IE in a typical teaching tertiary care centre in SA remains an important clinical problem. In this setting, it continues to affect mainly young people with post-inflammatory valve disease and congenital disease and is associated with in-hospital mortality that is quite high at almost 20%. Intravenous drug-associated endocarditis caused by S. aureus is an important IE subset, comprising ~10% of all cases, which was not reported 15 years ago, and culture-negative endocarditis remains highly prevalent. Heart failure in IE carries a significant risk of death and needs a more intensive level of care in hospital. Finally, cardiac surgery reduced mortality and had most impact in patients with heart failure. These findings suggest that prospective cohorts of IE are needed to keep track of changing trends and profiles in order to provide clinicians with more robust information to inform their clinical practice and thereby improve patient outcomes.
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